PREVALENCE OF GENERALIZED ANXIETY DISORDER AND RELATED FACTORS IN PATIENTS WITH CIRRHOSIS PATIENTS AT THE GASTROENTEROLOGY DEPARTMENTVIET TIEP FRIENDSHIP HOSPITAL IN 2025
Main Article Content
Abstract
Objective: To determine the prevalence and investigate some factors related to anxiety disorders in cirrhotic patients at the Gastroenterology Department - Viet Tiep Friendship Hospital in 2025.
Method: Cross-sectional descriptive study, convenient sampling on 144 cirrhotic patients at the Gastroenterology Department - Viet Tiep Friendship Hospital from January to March 2025.
Results: The prevalence of anxiety disorders was 43,1%; of which patients with mild anxiety disorders accounted for 24,3%. Analysis of some related factors showed: There was a statistically significant correlation between anxiety status and disease stage and frequency of hospitalization in the past year. There was no correlation between anxiety status and age group, gender, cause of disease, or caregiver.
Conclusion: 43,1% of cirrhotic patients had anxiety disorders, of which mild anxiety disorders accounted for 24,3%. There is a correlation between anxiety levels and disease progression and the frequency of hospitalizations in the past year. Therefore, to improve anxiety levels in patients, nurses need to clearly explain the disease, provide emotional support, especially for patients in the decompensated cirrhosis stage.
Article Details
Keywords
Anxiety disorder, cirrhosis, Viet Tiep Friendship Hospital.
References
[2] Kessler RC, Chiu WT, Demler O, et al: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):617-627, 2005. doi: 10.1001/archpsyc.62.6.617
[3] Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety Disorders and Cardiovascular Disease. Curr Psychiatry Rep. 2016 Nov;18(11):101. doi: 10.1007/s11920-016-0739-5. PMID: 27671918; PMCID: PMC5149447.
[4] Altintas E, Bagir GS, Haydardedeoglu FE, Bag H. Effect of health anxiety on glycemic control in patients with type 2 diabetes mellitus: A single center, cross sectional study. Acta Endocrinol (Buchar). 2023 Jan-Mar;19(1):73-80. doi: 10.4183/aeb.2023.73. Epub 2023 Aug 14. PMID: 37601723; PMCID: PMC10439319.
[5] Amiri S (2024) The prevalence of anxiety symptoms/disorders in cancer patients: a meta-analysis. Front. Psychiatry 15:1422540. doi: 10.3389/fpsyt.2024.1422540
[6] GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020. 5(3), 245-266, https://doi.org/10.1016/s2468-1253(19)30349-8.
[7] Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessinggeneralized anxiety disorder: the GAD-7. Archives of internal medicine. May 22 2006;166(10):1092- 1097. PMID: 16717171
[8] Hernaez R, Kramer JR, et al. Depression and Anxiety Are Common Among Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2022 Jan;20(1):194-203.e1. doi: 10.1016/j.cgh.2020.08.045. Epub 2020 Aug 21. PMID: 32835845; PMCID: PMC8210475.
[9] Abureesh O, Al-Shraideh A, Sleiman J, et al. Global prevalence and predictors of depression and anxiety in patients with liver cirrhosis: a systematic review and meta-analysis. Front Epidemiol. 2026 Apr 17;6:1740227. doi: 10.3389/fepid.2026.1740227. PMID: 42077634; PMCID: PMC13133006.